US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RenovoRx Inc

0.8050

-0.0355-4.22%

Volume:108.20K

Turnover:86.45K

Market Cap:29.50M

PE:-2.27

High:0.8200

Open:0.8200

Low:0.7700

Close:0.8405

52wk High:1.45

52wk Low:0.7006

Shares:36.65M

Float Shares:30.09M

Volume Ratio:1.49

T/O Rate:0.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3554

EPS(LYR):-0.3958

ROE:-146.61%

ROA:-68.39%

PB:3.65

PE(LYR):-2.03

Loading ...

Overview Company News Filings

RenovoRx price target lowered to $3 from $3.50 at Alliance Global

RenovoRx Expands Reach with RenovoCath Approval

Cancer drug developer RenovoRx's Q3 net loss widens

RenovoRx Q3 EPS $(0.08), Inline, Sales $266.000K Miss $405.333K Estimate

BRIEF-RenovoRx Q3 Net Income USD -2.912 Million

RenovoRx Inc: Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn

THOMSON REUTERS

Press Release: RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

RenovoRx Treats First Patient in RenovoCath Clinical Trial

RenovoRx Strengthens Scientific Advisory Board (SAB) With Pancreatic Cancer Expert Timothy Donahue, Md

THOMSON REUTERS

Press Release: RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET

RenovoRx Expands Scientific Advisory Board With Internationally Renowned Interventional Oncologist, Thierry De BaÈRe, Md, Phd

THOMSON REUTERS

Press Release: RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD

RenovoRx Inc publishes investor presentation highlighting RenovoCath commercialization and cancer therapy platform

RenovoRx announces first patient procedure completed in PanTheR study

RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th

RenovoRx Inc. Unveils Investor Presentation Highlighting TAMP Therapy Platform and Progress in Pancreatic Cancer Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNXT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNXT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNXT\",,,,,undefined,":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":0.805,"timestamp":1772811461581,"preClose":0.8405,"halted":0,"volume":108195,"delay":0,"changeRate":-0.04223676383105292,"floatShares":30093240,"shares":36649916,"eps":-0.3554,"marketStatus":"Trading","change":-0.0355,"latestTime":"03-06 10:38:52 EST","open":0.82,"high":0.82,"low":0.77,"amount":86452.392468,"amplitude":0.059488,"askPrice":0.8553,"askSize":200,"bidPrice":0.8,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.3554,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772830800000},"marketStatusCode":2,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":0.8405,"preHourTrading":{"tag":"盘前","latestPrice":0.82,"preClose":0.8405,"latestTime":"09:28 EST","volume":2404,"amount":1976.1355992,"timestamp":1772807325267,"change":-0.0205,"changeRate":-0.02439,"amplitude":0.059369},"postHourTrading":{"tag":"盘后","latestPrice":0.8237,"preClose":0.8405,"latestTime":"19:55 EST","volume":1515,"amount":1256.8314,"timestamp":1772758515008,"change":-0.0168,"changeRate":-0.019988,"amplitude":0.019988},"volumeRatio":1.488907},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNXT\",,,,,undefined,":{"symbol":"RNXT","floatShares":30093240,"roa":"-68.39%","roe":"-146.61%","lyrEps":-0.395758,"volumeRatio":1.488907,"shares":36649916,"dividePrice":0,"high":0.82,"amplitude":0.059488,"preClose":0.8405,"low":0.77,"week52Low":0.7006,"pbRate":"3.65","psRate":"31.79","week52High":1.45,"institutionHeld":0,"latestPrice":0.805,"committee":0.764706,"eps":-0.3554,"divideRate":0,"volume":108195,"delay":0,"ttmEps":-0.3554,"open":0.82,"prevYearClose":0.8401,"prevWeekClose":0.883,"prevMonthClose":0.883,"prevQuarterClose":0.8401,"fiveDayClose":0.883,"twentyDayClose":0.9509,"sixtyDayClose":0.9421},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNXT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"RNXT","fiscalQuarterEnding":"2025/09","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-08-14","symbol":"RNXT","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-05-15","symbol":"RNXT","fiscalQuarterEnding":"2025/03","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.08},{"date":"2025-04-01","symbol":"RNXT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743494400000,"name":null,"time":"Pre-Market","dateTimestamp":1743480000000,"actualEps":null},{"date":"2024-11-14","symbol":"RNXT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731574800000,"name":null,"time":"Pre-Market","dateTimestamp":1731560400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNXT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNXT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1769749200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNXT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNXT","date":"2026-03-04","current":-2.364941,"percent":0.602691,"low":-30.306305,"twenty":-4.39523,"median":-3.045274,"eighty":-2.027758,"high":-0.700344,"avg":-4.015689,"sd":3.580187,"marketCap":30536710},"quantilePoints":[{"date":"2021-08-13","current":-24.2365,"twenty":-25.044383,"median":-24.2365,"eighty":-24.2365,"marketCap":94401168},{"date":"2021-08-20","current":-21.299903,"twenty":-24.2365,"median":-24.2365,"eighty":-23.061861,"marketCap":94401168},{"date":"2021-08-27","current":-14.585618,"twenty":-24.2365,"median":-23.229503,"eighty":-21.299903,"marketCap":64643461},{"date":"2021-09-03","current":-14.926139,"twenty":-24.2365,"median":-22.222505,"eighty":-17.003313,"marketCap":66152647},{"date":"2021-09-10","current":-17.707054,"twenty":-24.2365,"median":-21.299903,"eighty":-17.570846,"marketCap":78477665},{"date":"2021-09-17","current":-14.358605,"twenty":-24.2365,"median":-18.86104,"eighty":-15.255308,"marketCap":63637337},{"date":"2021-09-24","current":-13.270832,"twenty":-24.2365,"median":-18.312424,"eighty":-14.44941,"marketCap":58816327},{"date":"2021-10-01","current":-11.180416,"twenty":-23.430902,"median":-16.88413,"eighty":-13.893227,"marketCap":49551603},{"date":"2021-10-08","current":-10.80206,"twenty":-22.222505,"median":-15.266659,"eighty":-12.708973,"marketCap":47874729},{"date":"2021-10-15","current":-11.31284,"twenty":-22.222505,"median":-15.049104,"eighty":-11.358243,"marketCap":50138508},{"date":"2021-10-22","current":-11.123662,"twenty":-21.853464,"median":-14.358605,"eighty":-11.210684,"marketCap":49300072},{"date":"2021-10-29","current":-9.799417,"twenty":-21.299903,"median":-13.923496,"eighty":-11.123662,"marketCap":43431015},{"date":"2021-11-05","current":-9.950759,"twenty":-20.339492,"median":-13.734318,"eighty":-10.809627,"marketCap":44101765},{"date":"2021-11-12","current":-15.418001,"twenty":-18.868607,"median":-13.809989,"eighty":-10.733956,"marketCap":68332582},{"date":"2021-11-19","current":-12.111555,"twenty":-18.664295,"median":-13.280291,"eighty":-10.809627,"marketCap":58704708},{"date":"2021-11-26","current":-11.743798,"twenty":-18.40323,"median":-12.901839,"eighty":-10.851246,"marketCap":56922187},{"date":"2021-12-03","current":-11.854254,"twenty":-18.19135,"median":-12.920217,"eighty":-11.002588,"marketCap":57457567},{"date":"2021-12-10","current":-10.78829,"twenty":-17.661651,"median":-12.442372,"eighty":-10.851198,"marketCap":52290840},{"date":"2021-12-17","current":-10.108278,"twenty":-17.241677,"median":-12.137848,"eighty":-10.650719,"marketCap":48994825},{"date":"2021-12-23","current":-9.354752,"twenty":-16.28822,"median":-11.835875,"eighty":-10.457473,"marketCap":45342483},{"date":"2021-12-31","current":-8.895285,"twenty":-16.080124,"median":-11.780739,"eighty":-10.29128,"marketCap":43115446},{"date":"2022-01-07","current":-7.406611,"twenty":-16.061206,"median":-11.68912,"eighty":-10.102102,"marketCap":35899844},{"date":"2022-01-14","current":-7.461747,"twenty":-15.436919,"median":-11.369594,"eighty":-9.924491,"marketCap":36167089},{"date":"2022-01-21","current":-6.616328,"twenty":-15.421785,"median":-11.31284,"eighty":-9.619405,"marketCap":32069340},{"date":"2022-01-28","current":-5.734151,"twenty":-15.296927,"median":-11.180416,"eighty":-9.185668,"marketCap":27793428},{"date":"2022-02-04","current":-6.267132,"twenty":-15.251525,"median":-11.137485,"eighty":-8.891609,"marketCap":30376791},{"date":"2022-02-11","current":-6.781736,"twenty":-15.187204,"median":-11.123662,"eighty":-7.991054,"marketCap":32871073},{"date":"2022-02-18","current":-6.616328,"twenty":-14.975325,"median":-10.97232,"eighty":-7.564668,"marketCap":32069340},{"date":"2022-02-25","current":-6.193618,"twenty":-14.858389,"median":-10.820978,"eighty":-7.391908,"marketCap":30020465},{"date":"2022-03-04","current":-5.899559,"twenty":-14.67666,"median":-10.738422,"eighty":-7.094174,"marketCap":28595161},{"date":"2022-03-11","current":-5.789287,"twenty":-14.44941,"median":-10.593964,"eighty":-6.700869,"marketCap":28060672},{"date":"2022-03-18","current":-5.697393,"twenty":-14.256449,"median":-10.43113,"eighty":-6.616328,"marketCap":27615265},{"date":"2022-03-25","current":-5.917937,"twenty":-14.040786,"median":-10.329115,"eighty":-6.436216,"marketCap":28684243},{"date":"2022-04-01","current":-4.09774,"twenty":-13.919712,"median":-10.253444,"eighty":-6.259781,"marketCap":25914105},{"date":"2022-04-08","current":-4.040628,"twenty":-13.893227,"median":-10.102102,"eighty":-6.175239,"marketCap":25552933},{"date":"2022-04-14","current":-3.69796,"twenty":-13.825123,"median":-9.950759,"eighty":-6.109076,"marketCap":23385899},{"date":"2022-04-22","current":-2.669956,"twenty":-13.599816,"median":-9.861954,"eighty":-5.939991,"marketCap":16884800},{"date":"2022-04-29","current":-2.386195,"twenty":-13.350954,"median":-9.685568,"eighty":-5.840747,"marketCap":15090295},{"date":"2022-05-06","current":-2.52908,"twenty":-13.276507,"median":-9.299616,"eighty":-5.653284,"marketCap":15993905},{"date":"2022-05-13","current":-2.017568,"twenty":-13.167344,"median":-9.09745,"eighty":-5.583445,"marketCap":16501690},{"date":"2022-05-20","current":-2.039739,"twenty":-12.982705,"median":-8.950513,"eighty":-5.429065,"marketCap":16683027},{"date":"2022-05-27","current":-2.194937,"twenty":-12.923893,"median":-8.674741,"eighty":-4.243374,"marketCap":17952388},{"date":"2022-06-03","current":-2.128424,"twenty":-12.854054,"median":-8.013108,"eighty":-4.126295,"marketCap":17408376},{"date":"2022-06-10","current":-2.139509,"twenty":-12.618807,"median":-7.737427,"eighty":-3.994939,"marketCap":17499045},{"date":"2022-06-17","current":-2.217108,"twenty":-12.420778,"median":-7.535262,"eighty":-3.515204,"marketCap":18133726},{"date":"2022-06-24","current":-2.316878,"twenty":-12.334401,"median":-7.406611,"eighty":-2.729121,"marketCap":18949743},{"date":"2022-07-01","current":-2.217108,"twenty":-12.164141,"median":-7.214094,"eighty":-2.52908,"marketCap":18133726},{"date":"2022-07-08","current":-2.26145,"twenty":-12.122072,"median":-7.094174,"eighty":-2.465843,"marketCap":18496400},{"date":"2022-07-15","current":-2.150595,"twenty":-11.905714,"median":-6.781736,"eighty":-2.350482,"marketCap":17589714},{"date":"2022-07-22","current":-2.158576,"twenty":-11.824848,"median":-6.662274,"eighty":-2.316453,"marketCap":17654995},{"date":"2022-07-29","current":-2.155583,"twenty":-11.78809,"median":-6.616328,"eighty":-2.281404,"marketCap":17630515},{"date":"2022-08-05","current":-2.245819,"twenty":-11.780739,"median":-6.556597,"eighty":-2.26145,"marketCap":18368557},{"date":"2022-08-12","current":-2.256416,"twenty":-11.780739,"median":-6.30389,"eighty":-2.26145,"marketCap":21352462},{"date":"2022-08-19","current":-1.964184,"twenty":-11.751186,"median":-6.276321,"eighty":-2.260443,"marketCap":18587069},{"date":"2022-08-26","current":-2.108,"twenty":-11.656314,"median":-6.211996,"eighty":-2.225976,"marketCap":19948005},{"date":"2022-09-02","current":-2.155811,"twenty":-11.467966,"median":-6.175239,"eighty":-2.217108,"marketCap":20400441},{"date":"2022-09-09","current":-2.673206,"twenty":-11.392295,"median":-6.129293,"eighty":-2.217108,"marketCap":25296547},{"date":"2022-09-16","current":-2.337857,"twenty":-11.335542,"median":-6.101724,"eighty":-2.217108,"marketCap":22123145},{"date":"2022-09-23","current":-1.758184,"twenty":-11.31284,"median":-5.945505,"eighty":-2.217108,"marketCap":16637693},{"date":"2022-09-30","current":-1.935439,"twenty":-11.278788,"median":-5.899559,"eighty":-2.211541,"marketCap":18315063},{"date":"2022-10-07","current":-1.906695,"twenty":-11.210684,"median":-5.807665,"eighty":-2.194937,"marketCap":18043057},{"date":"2022-10-14","current":-1.647998,"twenty":-11.180416,"median":-5.697393,"eighty":-2.176091,"marketCap":15595004},{"date":"2022-10-21","current":-1.667161,"twenty":-11.165684,"median":-5.6055,"eighty":-2.16168,"marketCap":15776341},{"date":"2022-10-28","current":-1.686323,"twenty":-11.144836,"median":-5.568742,"eighty":-2.1576,"marketCap":15957678},{"date":"2022-11-04","current":-1.772556,"twenty":-11.129191,"median":-5.476849,"eighty":-2.15572,"marketCap":16773696},{"date":"2022-11-11","current":-1.8013,"twenty":-11.123662,"median":-5.421713,"eighty":-2.146161,"marketCap":17045702},{"date":"2022-11-18","current":-1.704466,"twenty":-11.123662,"median":-4.247657,"eighty":-2.128424,"marketCap":17194654},{"date":"2022-11-25","current":-1.630786,"twenty":-11.123662,"median":-4.183407,"eighty":-2.102251,"marketCap":16451372},{"date":"2022-12-02","current":-1.695448,"twenty":-11.063125,"median":-4.09774,"eighty":-2.076152,"marketCap":17103677},{"date":"2022-12-09","current":-1.749558,"twenty":-10.972223,"median":-4.012073,"eighty":-2.044565,"marketCap":17649539},{"date":"2022-12-16","current":-1.975016,"twenty":-10.911637,"median":-3.712238,"eighty":-2.028843,"marketCap":19923965},{"date":"2022-12-23","current":-1.776613,"twenty":-10.813411,"median":-3.43382,"eighty":-2.017568,"marketCap":17922470},{"date":"2022-12-30","current":-2.11931,"twenty":-10.799306,"median":-2.965657,"eighty":-2.007604,"marketCap":21379597},{"date":"2023-01-06","current":-2.723539,"twenty":-10.78829,"median":-2.789053,"eighty":-2.01209,"marketCap":27475057},{"date":"2023-01-13","current":-2.71452,"twenty":-10.688553,"median":-2.729121,"eighty":-2.017568,"marketCap":27384080},{"date":"2023-01-20","current":-2.93096,"twenty":-10.650719,"median":-2.858814,"eighty":-2.017568,"marketCap":29567528},{"date":"2023-01-27","current":-2.38986,"twenty":-10.603423,"median":-2.72633,"eighty":-2.017568,"marketCap":24108907},{"date":"2023-02-03","current":-2.795685,"twenty":-10.503158,"median":-2.723539,"eighty":-2.020851,"marketCap":28202873},{"date":"2023-02-10","current":-3.435987,"twenty":-10.46207,"median":-2.762403,"eighty":-2.027258,"marketCap":34662240},{"date":"2023-02-17","current":-3.697519,"twenty":-10.415323,"median":-2.848984,"eighty":-2.029032,"marketCap":37300574},{"date":"2023-02-24","current":-3.381877,"twenty":-10.370734,"median":-2.904411,"eighty":-2.035494,"marketCap":34116378},{"date":"2023-03-03","current":-4.783906,"twenty":-10.336682,"median":-2.983441,"eighty":-2.039739,"marketCap":47308045},{"date":"2023-03-10","current":-3.983522,"twenty":-10.306414,"median":-3.291694,"eighty":-2.040397,"marketCap":39393045},{"date":"2023-03-17","current":-2.870344,"twenty":-10.279929,"median":-3.273658,"eighty":-2.04643,"marketCap":28384827},{"date":"2023-03-24","current":-2.424152,"twenty":-10.24966,"median":-3.026902,"eighty":-2.060536,"marketCap":23972442},{"date":"2023-03-31","current":-3.206137,"twenty":-10.158777,"median":-3.05902,"eighty":-2.070779,"marketCap":31705487},{"date":"2023-04-06","current":-2.714766,"twenty":-10.105808,"median":-3.026821,"eighty":-2.072996,"marketCap":26846321},{"date":"2023-04-14","current":-2.457093,"twenty":-10.08987,"median":-2.93096,"eighty":-2.076152,"marketCap":24298196},{"date":"2023-04-21","current":-2.806792,"twenty":-10.023216,"median":-2.901614,"eighty":-2.082163,"marketCap":27756366},{"date":"2023-04-28","current":-2.862008,"twenty":-9.950759,"median":-2.862008,"eighty":-2.085945,"marketCap":28302393},{"date":"2023-05-05","current":-2.687158,"twenty":-9.940252,"median":-2.860411,"eighty":-2.092613,"marketCap":26573308},{"date":"2023-05-12","current":-2.383473,"twenty":-9.899476,"median":-2.850464,"eighty":-2.100335,"marketCap":23570160},{"date":"2023-05-19","current":-2.147625,"twenty":-9.795633,"median":-2.806792,"eighty":-2.097749,"marketCap":21783365},{"date":"2023-05-26","current":-1.897902,"twenty":-9.761513,"median":-2.787545,"eighty":-2.081524,"marketCap":19250416},{"date":"2023-06-02","current":-2.10767,"twenty":-9.685568,"median":-2.751161,"eighty":-2.072996,"marketCap":21378093},{"date":"2023-06-09","current":-1.94475,"twenty":-9.487078,"median":-2.741546,"eighty":-2.04643,"marketCap":19725597},{"date":"2023-06-16","current":-2.237526,"twenty":-9.32167,"median":-2.72633,"eighty":-2.035494,"marketCap":22695227},{"date":"2023-06-23","current":-2.027758,"twenty":-9.299616,"median":-2.723539,"eighty":-2.028748,"marketCap":20567549},{"date":"2023-06-29","current":-2.237526,"twenty":-9.299616,"median":-2.714766,"eighty":-2.028296,"marketCap":22695227},{"date":"2023-07-07","current":-2.027758,"twenty":-9.262859,"median":-2.713947,"eighty":-2.028116,"marketCap":20567549},{"date":"2023-07-14","current":-2.287471,"twenty":-9.163614,"median":-2.691821,"eighty":-2.027758,"marketCap":23201817},{"date":"2023-07-21","current":-2.157614,"twenty":-9.075396,"median":-2.677956,"eighty":-2.028116,"marketCap":21884683},{"date":"2023-07-28","current":-1.907891,"twenty":-9.027685,"median":-2.668951,"eighty":-2.027758,"marketCap":19351734},{"date":"2023-08-04","current":-1.987802,"twenty":-8.961559,"median":-2.62274,"eighty":-2.017568,"marketCap":20162278},{"date":"2023-08-11","current":-2.037747,"twenty":-8.887933,"median":-2.586451,"eighty":-2.017568,"marketCap":20668867},{"date":"2023-08-18","current":-1.887658,"twenty":-8.79604,"median":-2.56076,"eighty":-2.00778,"marketCap":18642508},{"date":"2023-08-25","current":-1.862302,"twenty":-8.630632,"median":-2.554924,"eighty":-1.997747,"marketCap":18392097},{"date":"2023-09-01","current":-1.754029,"twenty":-8.343925,"median":-2.534153,"eighty":-1.981809,"marketCap":17322789},{"date":"2023-09-08","current":-1.624101,"twenty":-7.991054,"median":-2.52908,"eighty":-1.977813,"marketCap":16039620},{"date":"2023-09-15","current":-1.634928,"twenty":-7.877106,"median":-2.524344,"eighty":-1.960635,"marketCap":16146550},{"date":"2023-09-22","current":-1.494173,"twenty":-7.759482,"median":-2.505332,"eighty":-1.945586,"marketCap":14756450},{"date":"2023-09-29","current":-1.407554,"twenty":-7.67494,"median":-2.482915,"eighty":-1.935923,"marketCap":13901004},{"date":"2023-10-06","current":-1.245144,"twenty":-7.564668,"median":-2.457093,"eighty":-1.916598,"marketCap":12297042},{"date":"2023-10-13","current":-1.320935,"twenty":-7.520559,"median":-2.4447,"eighty":-1.906934,"marketCap":13045557},{"date":"2023-10-20","current":-1.231285,"twenty":-7.45072,"median":-2.424152,"eighty":-1.895408,"marketCap":12160170},{"date":"2023-10-27","current":-1.104389,"twenty":-7.428665,"median":-2.416648,"eighty":-1.892047,"marketCap":10906941},{"date":"2023-11-03","current":-1.093561,"twenty":-7.384557,"median":-2.38986,"eighty":-1.874119,"marketCap":10800010},{"date":"2023-11-10","current":-1.11121,"twenty":-7.315269,"median":-2.385764,"eighty":-1.860896,"marketCap":10974308},{"date":"2023-11-17","current":-0.730575,"twenty":-7.201137,"median":-2.373811,"eighty":-1.857523,"marketCap":6692798},{"date":"2023-11-24","current":-0.789791,"twenty":-7.127255,"median":-2.369212,"eighty":-1.848457,"marketCap":7235276},{"date":"2023-12-01","current":-0.747068,"twenty":-7.094174,"median":-2.357617,"eighty":-1.830181,"marketCap":6843891},{"date":"2023-12-08","current":-0.723606,"twenty":-7.086822,"median":-2.356303,"eighty":-1.821705,"marketCap":6628950},{"date":"2023-12-15","current":-1.12247,"twenty":-6.958171,"median":-2.32904,"eighty":-1.802247,"marketCap":10282946},{"date":"2023-12-22","current":-0.99185,"twenty":-6.75233,"median":-2.316878,"eighty":-1.784903,"marketCap":9086334},{"date":"2023-12-29","current":-1.715922,"twenty":-6.708221,"median":-2.316878,"eighty":-1.772556,"marketCap":15719562},{"date":"2024-01-05","current":-2.042764,"twenty":-6.697194,"median":-2.312997,"eighty":-1.772556,"marketCap":18713765},{"date":"2024-01-12","current":-1.319042,"twenty":-6.65676,"median":-2.307964,"eighty":-1.77187,"marketCap":12083745},{"date":"2024-01-19","current":-1.225659,"twenty":-6.634706,"median":-2.305792,"eighty":-1.762183,"marketCap":11228259},{"date":"2024-01-26","current":-1.237332,"twenty":-6.627355,"median":-2.293705,"eighty":-1.754072,"marketCap":11335194},{"date":"2024-02-02","current":-2.700107,"twenty":-6.616328,"median":-2.29746,"eighty":-1.754029,"marketCap":24735681},{"date":"2024-02-09","current":-2.847235,"twenty":-6.601625,"median":-2.305792,"eighty":-1.754072,"marketCap":26083523},{"date":"2024-02-16","current":-2.589899,"twenty":-6.561191,"median":-2.308695,"eighty":-1.754199,"marketCap":23726061},{"date":"2024-02-23","current":-2.498058,"twenty":-6.531785,"median":-2.314752,"eighty":-1.75507,"marketCap":22884711},{"date":"2024-03-01","current":-3.159309,"twenty":-6.480325,"median":-2.316878,"eighty":-1.758262,"marketCap":28942429},{"date":"2024-03-08","current":-3.214413,"twenty":-6.30389,"median":-2.32904,"eighty":-1.76038,"marketCap":29447239},{"date":"2024-03-15","current":-2.424586,"twenty":-6.300214,"median":-2.356303,"eighty":-1.767684,"marketCap":22211632},{"date":"2024-03-22","current":-2.700107,"twenty":-6.281835,"median":-2.357617,"eighty":-1.768604,"marketCap":24735681},{"date":"2024-03-28","current":-2.534794,"twenty":-6.267132,"median":-2.366602,"eighty":-1.770841,"marketCap":23221251},{"date":"2024-04-05","current":-1.973455,"twenty":-6.248754,"median":-2.362109,"eighty":-1.772556,"marketCap":20192392},{"date":"2024-04-12","current":-2.126379,"twenty":-6.211996,"median":-2.356763,"eighty":-1.772556,"marketCap":21757107},{"date":"2024-04-19","current":-2.840964,"twenty":-6.193618,"median":-2.356891,"eighty":-1.772556,"marketCap":29068743},{"date":"2024-04-26","current":-2.832222,"twenty":-6.175239,"median":-2.366602,"eighty":-1.776613,"marketCap":28979294},{"date":"2024-05-03","current":-2.972663,"twenty":-6.175239,"median":-2.371823,"eighty":-1.797338,"marketCap":30416284},{"date":"2024-05-10","current":-3.148214,"twenty":-6.138482,"median":-2.383473,"eighty":-1.8013,"marketCap":32212521},{"date":"2024-05-17","current":-4.343518,"twenty":-6.120103,"median":-2.387022,"eighty":-1.8013,"marketCap":34969664},{"date":"2024-05-24","current":-4.016267,"twenty":-6.101724,"median":-2.38986,"eighty":-1.8013,"marketCap":32334963},{"date":"2024-05-31","current":-3.480765,"twenty":-6.101724,"median":-2.406218,"eighty":-1.803194,"marketCap":28023635},{"date":"2024-06-07","current":-3.123763,"twenty":-6.072318,"median":-2.424369,"eighty":-1.803668,"marketCap":25149416},{"date":"2024-06-14","current":-3.123763,"twenty":-6.009831,"median":-2.429769,"eighty":-1.813745,"marketCap":25149416},{"date":"2024-06-21","current":-3.867516,"twenty":-5.951019,"median":-2.442232,"eighty":-1.82096,"marketCap":31137372},{"date":"2024-06-28","current":-3.451014,"twenty":-5.928964,"median":-2.442954,"eighty":-1.821457,"marketCap":27784117},{"date":"2024-07-05","current":-3.332014,"twenty":-5.90691,"median":-2.450362,"eighty":-1.821705,"marketCap":26826044},{"date":"2024-07-12","current":-3.480765,"twenty":-5.899559,"median":-2.461322,"eighty":-1.82441,"marketCap":28023635},{"date":"2024-07-15","current":-3.841633,"twenty":-5.899559,"median":-2.463437,"eighty":-1.825312,"marketCap":30928991},{"date":"2024-08-02","current":-3.659265,"twenty":-5.899559,"median":-2.465551,"eighty":-1.826214,"marketCap":29460744},{"date":"2024-08-09","current":-3.451014,"twenty":-5.862801,"median":-2.495981,"eighty":-1.82982,"marketCap":27784117},{"date":"2024-08-16","current":-3.277028,"twenty":-5.826044,"median":-2.500741,"eighty":-1.82982,"marketCap":26586525},{"date":"2024-08-23","current":-2.868178,"twenty":-5.789287,"median":-2.513304,"eighty":-1.830723,"marketCap":23269530},{"date":"2024-08-30","current":-3.045274,"twenty":-5.734151,"median":-2.521511,"eighty":-1.847957,"marketCap":24706310},{"date":"2024-09-06","current":-2.956577,"twenty":-5.704745,"median":-2.527177,"eighty":-1.847957,"marketCap":23986709},{"date":"2024-09-13","current":-3.163537,"twenty":-5.638581,"median":-2.534153,"eighty":-1.847957,"marketCap":25665778},{"date":"2024-09-20","current":-2.909272,"twenty":-5.609176,"median":-2.534794,"eighty":-1.848957,"marketCap":23602921},{"date":"2024-09-27","current":-3.060057,"twenty":-5.6055,"median":-2.550655,"eighty":-1.849282,"marketCap":24826243},{"date":"2024-10-04","current":-3.045274,"twenty":-5.6055,"median":-2.558322,"eighty":-1.855371,"marketCap":24706310},{"date":"2024-10-11","current":-2.94209,"twenty":-5.576094,"median":-2.581328,"eighty":-1.857735,"marketCap":23869174},{"date":"2024-10-18","current":-2.956577,"twenty":-5.568742,"median":-2.589899,"eighty":-1.857946,"marketCap":23986709},{"date":"2024-10-25","current":-2.749617,"twenty":-5.524633,"median":-2.6017,"eighty":-1.857946,"marketCap":22307639},{"date":"2024-10-31","current":-2.956577,"twenty":-5.469498,"median":-2.624687,"eighty":-1.858451,"marketCap":23986709},{"date":"2024-11-08","current":-3.144911,"twenty":-5.429065,"median":-2.630686,"eighty":-1.860896,"marketCap":25514662},{"date":"2024-11-15","current":-2.853379,"twenty":-5.421713,"median":-2.652961,"eighty":-1.862302,"marketCap":26145512},{"date":"2024-11-22","current":-3.167774,"twenty":-5.333495,"median":-2.669956,"eighty":-1.862302,"marketCap":29026316},{"date":"2024-11-29","current":-3.324579,"twenty":-5.096772,"median":-2.677956,"eighty":-1.864729,"marketCap":30463120},{"date":"2024-12-06","current":-3.612535,"twenty":-4.811505,"median":-2.691821,"eighty":-1.872202,"marketCap":33101658},{"date":"2024-12-13","current":-3.455468,"twenty":-4.783906,"median":-2.700107,"eighty":-1.878104,"marketCap":31662455},{"date":"2024-12-20","current":-3.010446,"twenty":-4.710085,"median":-2.714233,"eighty":-1.882064,"marketCap":27584715},{"date":"2024-12-27","current":-3.350757,"twenty":-4.584745,"median":-2.719152,"eighty":-1.887995,"marketCap":30702987},{"date":"2025-01-03","current":-3.560179,"twenty":-4.526311,"median":-2.72633,"eighty":-1.889342,"marketCap":32621924},{"date":"2025-01-10","current":-3.455468,"twenty":-4.511591,"median":-2.735883,"eighty":-1.892949,"marketCap":31662455},{"date":"2025-01-17","current":-3.691068,"twenty":-4.376397,"median":-2.749617,"eighty":-1.894597,"marketCap":33821259},{"date":"2025-01-24","current":-3.612535,"twenty":-4.327237,"median":-2.751576,"eighty":-1.895279,"marketCap":33101658},{"date":"2025-01-31","current":-3.531384,"twenty":-4.314599,"median":-2.779324,"eighty":-1.896985,"marketCap":32358070},{"date":"2025-02-07","current":-3.830678,"twenty":-4.286808,"median":-2.795685,"eighty":-1.897902,"marketCap":35100505},{"date":"2025-02-14","current":-2.702465,"twenty":-4.243374,"median":-2.803908,"eighty":-1.897902,"marketCap":24762685},{"date":"2025-02-21","current":-2.697957,"twenty":-4.213511,"median":-2.798354,"eighty":-1.898522,"marketCap":24721379},{"date":"2025-02-28","current":-2.619114,"twenty":-4.194062,"median":-2.787545,"eighty":-1.902349,"marketCap":23998938},{"date":"2025-03-07","current":-2.553367,"twenty":-4.18948,"median":-2.753394,"eighty":-1.907173,"marketCap":23396505},{"date":"2025-03-14","current":-3.959026,"twenty":-4.183407,"median":-2.750746,"eighty":-1.907891,"marketCap":36276557},{"date":"2025-03-21","current":-3.849571,"twenty":-4.176051,"median":-2.763158,"eighty":-1.911245,"marketCap":35273616},{"date":"2025-03-28","current":-3.959026,"twenty":-4.165017,"median":-2.787545,"eighty":-1.916277,"marketCap":36276557},{"date":"2025-04-04","current":-3.671929,"twenty":-4.160249,"median":-2.803908,"eighty":-1.916918,"marketCap":32364379},{"date":"2025-04-11","current":-3.279837,"twenty":-4.151505,"median":-2.828684,"eighty":-1.921875,"marketCap":28908480},{"date":"2025-04-17","current":-4.270837,"twenty":-4.1523,"median":-2.832222,"eighty":-1.92801,"marketCap":37643154},{"date":"2025-04-25","current":-4.187908,"twenty":-4.162633,"median":-2.832222,"eighty":-1.929949,"marketCap":36912219},{"date":"2025-05-02","current":-4.105394,"twenty":-4.1523,"median":-2.839244,"eighty":-1.935439,"marketCap":36184939},{"date":"2025-05-09","current":-4.312301,"twenty":-4.179729,"median":-2.842744,"eighty":-1.935923,"marketCap":38008622},{"date":"2025-05-16","current":-4.602552,"twenty":-4.19424,"median":-2.848984,"eighty":-1.937857,"marketCap":40566894},{"date":"2025-05-23","current":-4.42533,"twenty":-4.264347,"median":-2.853379,"eighty":-1.939236,"marketCap":44952504},{"date":"2025-05-30","current":-4.85707,"twenty":-4.270837,"median":-2.857222,"eighty":-1.94475,"marketCap":49338115},{"date":"2025-06-06","current":-5.040473,"twenty":-4.313409,"median":-2.868178,"eighty":-1.945021,"marketCap":51201124},{"date":"2025-06-13","current":-4.896459,"twenty":-4.374498,"median":-2.875122,"eighty":-1.94506,"marketCap":49738235},{"date":"2025-06-20","current":-4.968466,"twenty":-4.39523,"median":-2.888929,"eighty":-1.947289,"marketCap":50469680},{"date":"2025-06-27","current":-4.860456,"twenty":-4.470629,"median":-2.897445,"eighty":-1.947846,"marketCap":49372513},{"date":"2025-07-03","current":-4.896459,"twenty":-4.583199,"median":-2.902156,"eighty":-1.954946,"marketCap":49738235},{"date":"2025-07-11","current":-4.824453,"twenty":-4.667689,"median":-2.905735,"eighty":-1.959721,"marketCap":49006790},{"date":"2025-07-18","current":-4.680439,"twenty":-4.680439,"median":-2.909464,"eighty":-1.96241,"marketCap":47543901},{"date":"2025-07-25","current":-4.680439,"twenty":-4.680439,"median":-2.927011,"eighty":-1.968533,"marketCap":47543901},{"date":"2025-08-01","current":-4.464419,"twenty":-4.680439,"median":-2.93096,"eighty":-1.972646,"marketCap":45349567},{"date":"2025-08-08","current":-4.320405,"twenty":-4.680439,"median":-2.939436,"eighty":-1.973641,"marketCap":43886678},{"date":"2025-08-15","current":-4.464419,"twenty":-4.680439,"median":-2.94209,"eighty":-1.974516,"marketCap":45349567},{"date":"2025-08-22","current":-3.070089,"twenty":-4.667689,"median":-2.954419,"eighty":-1.976694,"marketCap":32739432},{"date":"2025-08-29","current":-3.256343,"twenty":-4.650337,"median":-2.956577,"eighty":-1.977813,"marketCap":34725639},{"date":"2025-09-05","current":-4.089329,"twenty":-4.637235,"median":-2.956577,"eighty":-1.977813,"marketCap":43608601},{"date":"2025-09-12","current":-4.261149,"twenty":-4.619233,"median":-2.956577,"eighty":-1.977813,"marketCap":45440896},{"date":"2025-09-19","current":-4.329877,"twenty":-4.608432,"median":-2.972663,"eighty":-1.981809,"marketCap":46173813},{"date":"2025-09-26","current":-4.020601,"twenty":-4.60608,"median":-2.986143,"eighty":-1.987802,"marketCap":42875684},{"date":"2025-10-03","current":-4.364242,"twenty":-4.603895,"median":-3.000334,"eighty":-1.99084,"marketCap":46540272},{"date":"2025-10-10","current":-3.84878,"twenty":-4.603895,"median":-3.015708,"eighty":-1.995667,"marketCap":41043390},{"date":"2025-10-17","current":-4.020601,"twenty":-4.601272,"median":-3.015708,"eighty":-1.996731,"marketCap":42875684},{"date":"2025-10-24","current":-3.951872,"twenty":-4.588583,"median":-3.015708,"eighty":-1.997747,"marketCap":42142766},{"date":"2025-10-31","current":-3.487957,"twenty":-4.572429,"median":-3.017315,"eighty":-1.997791,"marketCap":37195572},{"date":"2025-11-07","current":-3.318885,"twenty":-4.572429,"median":-3.030708,"eighty":-2.001268,"marketCap":35392594},{"date":"2025-11-14","current":-3.348439,"twenty":-4.571628,"median":-3.043553,"eighty":-2.007002,"marketCap":35707749},{"date":"2025-11-21","current":-2.568959,"twenty":-4.55668,"median":-3.030708,"eighty":-2.00778,"marketCap":28528294},{"date":"2025-11-28","current":-3.027702,"twenty":-4.534112,"median":-3.026821,"eighty":-2.00778,"marketCap":33622632},{"date":"2025-12-05","current":-3.135292,"twenty":-4.522631,"median":-3.02674,"eighty":-2.008423,"marketCap":34817420},{"date":"2025-12-12","current":-3.276875,"twenty":-4.506413,"median":-3.027702,"eighty":-2.011213,"marketCap":36389701},{"date":"2025-12-19","current":-2.970277,"twenty":-4.493804,"median":-3.027702,"eighty":-2.013186,"marketCap":32984924},{"date":"2025-12-26","current":-2.955425,"twenty":-4.467334,"median":-3.026902,"eighty":-2.017568,"marketCap":32819999},{"date":"2026-01-02","current":-2.772588,"twenty":-4.465002,"median":-3.017315,"eighty":-2.017568,"marketCap":30789594},{"date":"2026-01-09","current":-3.795354,"twenty":-4.464419,"median":-3.026821,"eighty":-2.017568,"marketCap":42147403},{"date":"2026-01-16","current":-3.399317,"twenty":-4.461931,"median":-3.027702,"eighty":-2.017729,"marketCap":37749413},{"date":"2026-01-23","current":-3.366314,"twenty":-4.461309,"median":-3.042883,"eighty":-2.018759,"marketCap":37382914},{"date":"2026-01-30","current":-3.168295,"twenty":-4.444306,"median":-3.043218,"eighty":-2.020771,"marketCap":35183919},{"date":"2026-02-06","current":-3.138262,"twenty":-4.428386,"median":-3.045274,"eighty":-2.025324,"marketCap":34850405},{"date":"2026-02-13","current":-3.069946,"twenty":-4.409296,"median":-3.047187,"eighty":-2.027758,"marketCap":34091751},{"date":"2026-02-20","current":-3.103939,"twenty":-4.397256,"median":-3.053545,"eighty":-2.027758,"marketCap":34469245},{"date":"2026-02-27","current":-2.854766,"twenty":-4.39523,"median":-3.045274,"eighty":-2.027758,"marketCap":31702177},{"date":"2026-03-04","current":-2.749816,"twenty":-4.39523,"median":-3.045274,"eighty":-2.027758,"marketCap":30536710}],"updateTime":1772774923795},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNXT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583168987","title":"RenovoRx price target lowered to $3 from $3.50 at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2583168987","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583168987?lang=en_us&edition=fundamental","pubTime":"2025-11-15 03:20","pubTimestamp":1763148032,"startTime":"0","endTime":"0","summary":"Alliance Global lowered the firm’s price target on RenovoRx (RNXT) to $3 from $3.50 and keeps a Buy rating on the shares after the company reported...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-price-target-lowered-to-3-from-3-50-at-alliance-global-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-price-target-lowered-to-3-from-3-50-at-alliance-global-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT"],"gpt_icon":0},{"id":"2583015517","title":"RenovoRx Expands Reach with RenovoCath Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2583015517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583015517?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:54","pubTimestamp":1763070890,"startTime":"0","endTime":"0","summary":"RenovoRx ( ($RNXT) ) has issued an announcement. RenovoRx reported its third-quarter 2025 financial results, highlighting approximately $900,000 in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renovorx-expands-reach-with-renovocath-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renovorx-expands-reach-with-renovocath-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2583120795","title":"Cancer drug developer RenovoRx's Q3 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2583120795","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583120795?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:38","pubTimestamp":1763069880,"startTime":"0","endTime":"0","summary":"Cancer drug developer RenovoRx's Q3 net loss widensOverviewRenovoRx Q3 revenue at $266,000, reflecting early-stage commercialization progressNet loss for Q3 2025 was $2.9 mln, compared to $2.5 mln in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP18R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0},{"id":"2583751418","title":"RenovoRx Q3 EPS $(0.08), Inline, Sales $266.000K Miss $405.333K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583751418","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583751418?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:11","pubTimestamp":1763068290,"startTime":"0","endTime":"0","summary":"RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year.  The company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48850358/renovorx-q3-eps-0-08-inline-sales-266-000k-miss-405-333k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0},{"id":"2583848514","title":"BRIEF-RenovoRx Q3 Net Income USD -2.912 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583848514","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583848514?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067950,"startTime":"0","endTime":"0","summary":"BRIEF-RenovoRx Q3 Net Income USD -2.912 Million\n\n\nNov 13 (Reuters) - RenovoRx Q3 operating expenses USD 3.413 million.\n\nQ3 basic EPS USD -0.08","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX8457A8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2583517511","title":"RenovoRx Inc: Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn","url":"https://stock-news.laohu8.com/highlight/detail?id=2583517511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583517511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067905,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX8457A8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2583151487","title":"Press Release: RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583151487","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583151487?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067900,"startTime":"0","endTime":"0","summary":"September 30, 2025 Cash and Cash Equivalents at $10 million. Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn. Management to Host Conference Call Today at 4:30 p.m. ET. \"We continue to make strong progress both in our commercial and clinical activities,\" said Shaun Bagai, CEO of RenovoRx. \"On the commercial side, we are encouraged by the continued RenovoCath clinical adoption we are seeing in the field. Year-to-date revenue, through the end of the third quarter, was approximately $900,000, reflecting the growing clinical need and market demand for targeted drug-delivery solutions. Since organically launching commercial sales less than a year ago, we have expanded from five centers at the start of 2025 to 14 leading cancer centers now approved to purchase RenovoCath, including several that have already made repeat orders.\". RenovoRx continued to execute on its RenovoCath commercialization strategy in the third quarter of 2025, demonstrating progress as year-to-date reve","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0},{"id":"2582395639","title":"RenovoRx Treats First Patient in RenovoCath Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2582395639","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582395639?lang=en_us&edition=fundamental","pubTime":"2025-11-12 00:54","pubTimestamp":1762880041,"startTime":"0","endTime":"0","summary":"RenovoRx Inc. has announced the initiation of patient treatment in its clinical trial evaluating the RenovoCath drug delivery device, which is cleared by the U.S. Food and Drug Administration. The first patient was treated at the University of Vermont Cancer Center. Additional clinical sites, including Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center, have joined the PanTheR registry study and are expected to begin patient procedures soon. The results of this study have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL4jLWFb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2581774095","title":"RenovoRx Strengthens Scientific Advisory Board (SAB) With Pancreatic Cancer Expert Timothy Donahue, Md","url":"https://stock-news.laohu8.com/highlight/detail?id=2581774095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581774095?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:30","pubTimestamp":1762435803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUABHXJPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2581096800","title":"Press Release: RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096800?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:30","pubTimestamp":1762435800,"startTime":"0","endTime":"0","summary":"MOUNTAIN VIEW, Calif., Nov. 06, 2025  -- RenovoRx, Inc.  , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath , a novel, FDA-cleared drug-delivery device, today announced the appointment of renowned UCLA surgeon and pancreatic disease expert Timothy Donahue, MD, to RenovoRx's scientific advisory board .Dr. Donahue is a nationally recognized expert in pancreatic cancer and serves as the Director of UCLA's Agi Hirshberg Center for Pancreatic Diseases and as Chief of the Division of Surgical Oncology at the David Geffen School of Medicine. He also holds the Garry Shandling Chair in Pancreatic Surgery and maintains a joint appointment in the Department of Molecular and Medical Pharmacology, where he leads an active research program focused on advancing management of pancreatic cancer.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4022","BK4139","BK4555","MD","BK4604","BK4539","R","BK4232","BK4196","BK4585","IAG","03160","RNXT","BK4017","BK4588","BK4099"],"gpt_icon":0},{"id":"2580573216","title":"RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th","url":"https://stock-news.laohu8.com/highlight/detail?id=2580573216","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580573216?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:30","pubTimestamp":1762263000,"startTime":"0","endTime":"0","summary":"MOUNTAIN VIEW, Calif., Nov.  04, 2025  (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180350/0/en/RenovoRx-CEO-Shaun-Bagai-to-Participate-at-the-Canaccord-Genuity-MedTech-Diagnostics-Digital-Health-Services-Forum-on-November-20th.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAG","BK4139","BK4017","BK4179","BK4539","RNXT","FET"],"gpt_icon":0},{"id":"2578768641","title":"RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2578768641","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578768641?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568200,"startTime":"0","endTime":"0","summary":"MOUNTAIN VIEW, Calif., Oct.  27, 2025  (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174593/0/en/RenovoRx-to-Host-Third-Quarter-2025-Financial-Results-and-Business-Highlights-Conference-Call-on-November-13th-at-4-30-p-m-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNXT","BK4017","IAG","ET","BK4181","BK4585","BK4539","BK4581","HST","BK4218","BK4144","BK4590","BK4588","BK4561"],"gpt_icon":0},{"id":"2574415279","title":"RenovoRx Expands Scientific Advisory Board With Internationally Renowned Interventional Oncologist, Thierry De BaÈRe, Md, Phd","url":"https://stock-news.laohu8.com/highlight/detail?id=2574415279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574415279?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:30","pubTimestamp":1760013002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nTUA4CB545:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0},{"id":"2574152093","title":"Press Release: RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD","url":"https://stock-news.laohu8.com/highlight/detail?id=2574152093","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574152093?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:30","pubTimestamp":1760013000,"startTime":"0","endTime":"0","summary":"LOS ALTOS, Calif., Oct. 09, 2025  -- RenovoRx, Inc.  , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath , a novel, FDA-cleared drug-delivery device, today announced the appointment of renowned interventional oncologist Thierry de Baère, MD, PhD to RenovoRx's Scientific Advisory Board .Professor de Baère's expertise is directly relevant to RenovoRx's Trans-Arterial Micro-Perfusion  therapy platform which is enabled by RenovoCath. This patented technology is designed to optimize targeted drug-delivery of therapeutic agents.RenovoRx, Inc.  is a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath , a novel, U.S. Food and Drug Administration -cleared local drug-delivery device, targeting high unmet medical needs. RenovoRx's patented Trans-Arterial Micro-Perfusion  therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site to bathe the ta","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4139","03160","BK4539","BK4555","R","BK4585","BK4588","BK4196","BK4099","MD","RNXT","TM","BK4232","BK4022"],"gpt_icon":0},{"id":"2573966588","title":"RenovoRx Inc publishes investor presentation highlighting RenovoCath commercialization and cancer therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2573966588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573966588?lang=en_us&edition=fundamental","pubTime":"2025-10-07 22:48","pubTimestamp":1759848501,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief on October 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL3NvpXq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2570097221","title":"RenovoRx announces first patient procedure completed in PanTheR study","url":"https://stock-news.laohu8.com/highlight/detail?id=2570097221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570097221?lang=en_us&edition=fundamental","pubTime":"2025-09-25 20:40","pubTimestamp":1758804044,"startTime":"0","endTime":"0","summary":"RenovoRx (RNXT) announced that the first registry-eligible patient procedure in its PanTheR Post-Marketing Registry Study has been successfully com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-announces-first-patient-procedure-completed-in-panther-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-announces-first-patient-procedure-completed-in-panther-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2570090169","title":"RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2570090169","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570090169?lang=en_us&edition=fundamental","pubTime":"2025-09-25 20:30","pubTimestamp":1758803400,"startTime":"0","endTime":"0","summary":"First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/25/3156272/0/en/RenovoRx-s-PanTheR-Post-Marketing-Registry-Study-Progresses-with-First-Clinical-Procedure-and-Addition-of-Two-Participating-Clinical-Sites.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","RNXT","BK4539","POST","BK4139"],"gpt_icon":0},{"id":"2566991139","title":"RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th","url":"https://stock-news.laohu8.com/highlight/detail?id=2566991139","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566991139?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:30","pubTimestamp":1757593800,"startTime":"0","endTime":"0","summary":"MOUNTAIN VIEW, Calif., Sept.  11, 2025  (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/11/3148530/0/en/RenovoRx-CEO-Shaun-Bagai-to-Present-at-iAccess-Alpha-Virtual-Best-Ideas-Fall-Investment-Conference-2025-on-September-16th.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0},{"id":"2564336475","title":"RenovoRx Inc. Unveils Investor Presentation Highlighting TAMP Therapy Platform and Progress in Pancreatic Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2564336475","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564336475?lang=en_us&edition=fundamental","pubTime":"2025-09-03 06:29","pubTimestamp":1756852143,"startTime":"0","endTime":"0","summary":"RenovoRx Inc., a NASDAQ-listed company, has shared insights from its recent investor presentation. The company is advancing its proprietary Trans-Arterial Micro-Perfusion  platform, which combines RenovoCath with Gemcitabine for treating pancreatic and bile duct cancers. This combination has received FDA Orphan Drug Designation. RenovoRx has initiated the commercialization of its FDA-cleared RenovoCath device, with revenues in the first half of 2025 exceeding expectations. Currently, four cancer centers are using the device, with more than 20 potential customers in discussions. The ongoing Phase III TIGeR-PaC study for locally advanced pancreatic cancer has shown promising results, with a significant reduction in adverse effects. The study's enrollment is expected to conclude by late 2025 or early 2026. RenovoRx aims to pursue a potential peak annual U.S. revenue opportunity of approximately $400 million for RenovoCath as a stand-alone device, with plans to expand its applications furt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL47kNN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}